EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

2025 Consensus Clinical Management Guidelines for Niemann‐Pick Disease Type C

Tarekegn Hiwot iD, Forbes D Porter iD, Tatiana Bremova-Ertl, Uma Ramaswami iD, Caroline Hastings iD, Bénédicte Héron, Justin Hopkin, Joella Melville, Hernan Amartino, Mireia Del Toro, Federica Deodato iD, Fatih Ezgü und 22 weitere

Journal of Inherited Metabolic Disease · 2026-05 · 49 (3)

DOI: 10.1002/jimd.70185 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 26.04.2026. Verfasst von Tarekegn Hiwot und 33 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolism and System Research, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Niemann-Pick Disease, Type C. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Niemann-Pick Disease Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2018, the International Niemann‐Pick Disease Alliance (INPDA) and the International Niemann‐Pick Disease Registry (INPDR) developed and published comprehensive clinical management guidelines to support inclusive and standardized care pathways in Niemann‐Pick disease type C (NPC)—an ultra‐rare, autosomal recessive, neurovisceral lysosomal disorder. Since then, advances in diagnostics, care, and the approval of two novel disease‐modifying agents have underscored the need to revise these guidelines to ensure safe, consistent, and high‐quality care for those affected by NPC. In response, the INPDA and INPDR convened a multidisciplinary Guidelines Development Group (GDG) comprising individuals with NPC expertise from 14 countries across five continents, representing a broad range of specialties, as well as patients and families involved in NPC care. Informed by a comprehensive literature review and two meetings, the GDG systematically reviewed, revised, and updated the 2018 guideline statements, re‐evaluating the level of evidence, strength of recommendations, and expert agreement for each. The resulting 2025 consensus clinical management guidelines constitute a timely, up‐to‐date, and internationally applicable resource for the diagnosis, treatment, and holistic management of individuals with NPC. These guidelines serve as a critical resource for specialist centers, hospital‐based medical teams, staff involved in NPC patient care, family physicians and other primary caregivers, and, importantly, patients and their families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Niemann-Pick Disease, Type CHumansConsensusPractice Guidelines as TopicDisease Management

Stichwörter der Autor:innen

NPCNiemann‐Pick disease type Cdiagnosisguidelinesmanagementtreatment

Autor:innen und Institutionen

  • Institute of Metabolism and System Research, University of Birmingham, Birmingham, UK.
  • Department of Endocrinology, University Hospital Birmingham, Birmingham, UK.
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Neurology, University Hospital Inselspital, Bern, Switzerland.
  • Royal Free London NHS Foundation Trust, London, UK.
  • University College London, London, UK.

ORCID-Profile: Tarekegn Hiwot, Forbes D Porter, Uma Ramaswami, Caroline Hastings, Federica Deodato, Kristina Julich, Yann Nadjar, Ozlem Goker-Alpan, Toni Mathieson

Förderung

  • International Niemann-Pick Disease Alliance

Zitieren

APA

Hiwot, T., Porter, F. D., Bremova-Ertl, T., Ramaswami, U., Hastings, C., Héron, B., Hopkin, J., Melville, J., Amartino, H., Del Toro, M., Deodato, F., Ezgü, F., Gissen, P., Gibson, J. B., Ficicioglu, C., Giugliani, R., Staretz-Chacham, O., Platt, F., Guffon, N., …, & Patterson, M. C. (2026). 2025 Consensus Clinical Management Guidelines for Niemann‐Pick Disease Type C. Journal of Inherited Metabolic Disease, 49(3). https://doi.org/10.1002/jimd.70185

Vancouver

Hiwot T, Porter FD, Bremova-Ertl T, Ramaswami U, Hastings C, Héron B, et al. 2025 Consensus Clinical Management Guidelines for Niemann‐Pick Disease Type C. Journal of Inherited Metabolic Disease. 2026;49(3). doi:10.1002/jimd.70185

BibTeX
@article{Hiwot2026,
  author = {Hiwot, Tarekegn and Porter, Forbes D and Bremova-Ertl, Tatiana and Ramaswami, Uma and Hastings, Caroline and Héron, Bénédicte and Hopkin, Justin and Melville, Joella and Amartino, Hernan and Del Toro, Mireia and Deodato, Federica and Ezgü, Fatih and Gissen, Paul and Gibson, James B and Ficicioglu, Can and Giugliani, Roberto and Staretz-Chacham, Orna and Platt, Frances and Guffon, Nathalie and Julich, Kristina and Kresojević, Nikola and Lehman, Anna and Nadjar, Yann and Schneider, Susanne A and Jones, Simon and Mengel, Eugen and Tchan, Michel and Walterfang, Mark and Goker-Alpan, Ozlem and Dawson, Charlotte and Cowie, Sandra and Mathieson, Toni and Berry-Kravis, Elizabeth and Patterson, Marc C},
  title = {2025 Consensus Clinical Management Guidelines for Niemann‐Pick Disease Type C},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  volume = {49},
  number = {3},
  doi = {10.1002/jimd.70185}
}
Kostenlos starten →